Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-12-01T01:23:35.328Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of a best practice alert linking Clostridioides difficile infection test results to a severity-based treatment order set

Published online by Cambridge University Press:  25 February 2019

Holly L. Reed Open the ORCID record for Holly L. Reed [Opens in a new window] ,
Trevor C. Van Schooneveld ,
Craig G. Reha  and
Scott J. Bergman
Holly L. Reed*
Affiliation:
Department of Pharmaceutical and Nutrition Care, Nebraska Medicine, Omaha, Nebraska
Trevor C. Van Schooneveld
Affiliation:
Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska
Craig G. Reha
Affiliation:
Department of Pharmaceutical and Nutrition Care, Nebraska Medicine, Omaha, Nebraska
Scott J. Bergman
Affiliation:
Department of Pharmaceutical and Nutrition Care, Nebraska Medicine, Omaha, Nebraska
*
Author for correspondence: Holly Reed, Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

We evaluated provider adherence to practice guidelines for inpatients diagnosed with Clostridoides difficile infection (CDI) before and after implementation of a best practice alert (BPA) linking a positive test result to guideline-based orders. After implementation of the BPA, guideline-based prescribing increased from 39.4% in 2013 to 67.7% in 2016 (P = .014).

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 4 , April 2019 , pp. 467 - 469
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridoides difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America. Clostridoides difficile 2010;31:431–455.Google Scholar
Surawicz, CM, Brandt, LJ, Binion, DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridoides difficile infections. Am J Gastroenterol 2013;108:478–498.CrossRefGoogle Scholar
Wieczorkiewicz, S, Zatarski, R. Adherence to and outcomes associated with a Clostridoides difficile guideline at a large teaching institution. Hosp Pharm 2015;50:42–50.CrossRefGoogle Scholar
Brown, AT, Seifert, CF. Effect of treatment variation on outcomes in patients with Clostridoides difficile. Am J Med 2014;127:865–870.CrossRefGoogle Scholar
Zar, FA, Bakkanagari, SR, Moorthi, KM, Davis, MB. A comparison of vancomycin and metronidazole for the treatment of Clostridoides difficile–associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302–307.CrossRefGoogle Scholar
Stevens, VW, Nelson, RE, Schwab-Daugherty, EM, et al. Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridoides difficile infection. JAMA Intern Med 2017;177:546–553.CrossRefGoogle Scholar
Wright, A, Phansalkar, S, Bloomrosen, M, et al. Best practices in clinical decision support. The case of preventive care reminders. Appl Clin Inform 2010;1:331–345.Google ScholarPubMed
Wenisch, JM, Schmid, D, Kuo, HW, et al. Prospective observational study comparing three different treatment regimens in patients with Clostridoides difficile infection. Antimicrob Agents Chemother 2012;56:1974–1978.CrossRefGoogle Scholar
Revolinski, S. Implementation of a clinical decision support alert for the management of Clostridoides difficile infection. Antibiotics (Basel, Switzerland) 2015;4:667–674.Google Scholar
McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridoides difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clostridoides difficile 2018;66(7):e1–e48.Google Scholar
Supplementary material: File

Reed et al. supplementary material

Reed et al. supplementary material 1

Download Reed et al. supplementary material(File)
File 14.5 KB